Bradykinin decreases outflow facility in perfused anterior segments and induces shape changes in passed BTM cells in vitro

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 1, 1999, Pages 113-125

  Llobet, Artur ^a   Gual, Arcadi ^a,d   Palés, Jordi ^a   Barraquer, Rafael ^b   Tobías, Ester ^c   Nicolás, Josep M ^c  

^a Dept de Ciencies Fisiologiques   (Spain)

^b INSTITUT UNIVERSITARI BARRAQUER   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; BRADYKININ RECEPTOR; CALCIUM ION; CALMODULIN INHIBITOR; ICATIBANT; THAPSIGARGIN;

ANIMAL CELL; ANIMAL TISSUE; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR OUTFLOW; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CATTLE; CELL SHAPE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; KALLIKREIN KININ SYSTEM; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; TRABECULAR MESHWORK;

AGED; AGED, 80 AND OVER; ANIMALS; AQUEOUS HUMOR; BRADYKININ; CALCIUM; CALMODULIN; CATTLE; CELL SIZE; CELLS, CULTURED; FURA-2; HUMANS; PERFUSION; RECEPTORS, BRADYKININ; SULFONAMIDES; TRABECULAR MESHWORK;

EID: 0032953556     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Igic R. Kallikrein and kininases in ocular tissues. Exp Eye Res. 1985;41:117-120.
2. Laliberte MF, Laliberte F, Alhene Gelas F, Chevillard C. Immunohistochemistry of angiotensin I-converting enzyme in rat eye structures involved in aqueous humor regulation. Lab Invest. 1988;59: 263-270
3. Ma JX, Song Q, Hatcher HC, Crouch RK, Chao L, Chao J. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Exp Eye Res. 1996;63:19-26.
4. Sharif NA, Xu SX. Pharmacological characterization of bradykinin receptors coupled to phosphoinositide turnover in SV40-immortalized human trabecular meshwork cells. Exp Eye Res. 1996;63: 631-637.
5. Mombouli JV, Vanhoutte PM. Kinins and endothelial control of vascular smooth muscle. Annu Rev Pharmacol Toxicol. 1995;35: 679-705.
6. Dray A, Perkins M. Bradykinin and inflammatory pain (see comments). Trends Neurosci. 1993;16:99-104.
7. Bynke G, Hakanson R, Horig J, Leander S. Bradykinin contracts the pupillary sphincter and evokes ocular inflammation through release of neuronal substance P. Eur J Pharmacol. 1983;91:469-475.
8. Eakins K, Stier C, Bhattacherjee P, Greenbaum L. Actions and interactions of bradykinin, prostaglandins, and nonsteroidal antiinflammatory agents on the eye. Inflammation. 1976;1:117-125.
9. Chiang TS. Effects of intravenous infusions of histamine 5-hydroxytryptamine, bradykinin and prostaglandins on intraocular pressure. Arch Int Pharmacodyn Ther. 1974;207:131-138.
10. Funk R, Rohen JW, Skolasinska K. Intraocular pressure and systemic blood pressure after administration of vasoactive substances in hypertensive and normal rats. Graefes Arch Clin Exp Ophthalmol. 1985;223:145-149.
11. Cole D, Unger W. Action of bradykinin on intraocular pressure and pupillary diameter. Ophthalmic Res. 1974;6:308-314.
12. Yokoyama K, Awaya S, Mizumura K, Kumazawa T. Implication of polymodal receptor activities in intraocular pressure elevation by neurogenic inflammation. Jpn J Ophthalmol. 1990;34: 245-255.
13. Stamer WD, Seftor RE, Williams SK, Samaha HA, Snyder RW. Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr Eye Res. 1995;14:611-617.
14. Grynkiewicz G, Poenic M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440-3450.
15. Erickson Lamy K, Rohen JW, Grant WM. Outflow facility studies in the perfused bovine aqueous outflow pathways. Curr Eye Res. 1988;7:799-807.
16. Erickson Lamy K, Rohen JW, Grant WM. Outflow facility studies in the perfused human ocular anterior segment. Exp Eye Res. 1991; 52:723-731.
17. Gual A, Llobet A, Gilabert R, et al. Effects of time of storage, albumin, and osmolality changes on outflow facility (C) of bovine anterior segment in vitro. Invest Ophthalmol Vis Sci. 1997;38: 2165-2171.
18. Stewart JM, Gera L, Hanson W, et al. A new generation of bradykinin antagonists. Immunopharmacology. 1996;33:51-60.
19. Alexander S, Peters J. Receptor & ion channel nomenclature supplement. Trends Pharmacol Sci. 1997;8:19-20.
20. Grierson I, Robins E, Unger W, Millar L, Ahmed A. The cells of the bovine outflow system in tissue culture. Exp Eye Res. 1985;40:35-46.
21. Crean EV, Sherwood ME, Casey R, Miller MW, Richardson TM. Establishment of call trabecular meshwork cell cultures. Exp Eye Res. 1986;43:503-517.
22. Coroneo MT, Korbmacher C, Flugel C, Stiemer B, Lutjen Drecoll E, Wiederholt M. Electrical and morphological evidence for heterogeneous populations of cultured bovine trabecular meshwork cells. Exp Eye Res. 1991;52:375-388.
23. Tripathi BJ, Li T, Li J, Tran L, Tripathi RC. Age-related changes in trabecular cells in vitro. Exp Eye Res. 1997,64:57-66.
24. Tanihara H, Ohuchi T, Yoshimura N, Negishi M, Ito S. Heterogeneous response in calcium signaling by adrenergic and cholinergic stimulation in cultured bovine trabecular cells. Exp Eye Res. 1991; 52:393-396.
25. 2+], transients in cultured bovine trabecular cells. Invest Ophthalmol Vis Sci. 1992;33:1676-1684.
26. 2, bradykinin, neuropeptide Y and substance P on intracellular calcium in bovine trabecular meshwork cells and on outflow facility in anterior segments in vitro [AHVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(3):S490. Abstract nr 2259.
27. Luckhoff A, Zeh R, Busse R. Desensitization of the bradykinin-induced increase in intracellular free calcium in cultured endothelial cells. Pflugers Arch. 1988;412:654-658.
28. Wolsing DH, Rosenbaum JS. The mechanism for the rapid desensitization in bradykinin-stimulated inositol monophosphate production in NG108-15 cells involves interaction of a single receptor with multiple signaling pathways. J Pharmacol Exp Ther. 1993; 266:253-261.
29. Luo H, Lindeman RP, Chase HS Jr. Participation of protein kinase C in desensitization to bradykinin and to carbachol in MDCK cells. Am J Physiol. 1992;262:F499-F506.
30. McGehee DS, Goy MF, Oxford GS. Involvement of the nitric oxide-cyclic GMP pathway in the desensitization of bradykinin responses of cultured rat sensory neurons. Neuron. 1992;9:315-324.
31. Babe KS, Serafin WE. Histamine, bradykinin and their antagonists. In: Hardmann JG, Gilman AG, Limbird LE, eds. The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw Hill. 1996; 581-600
32. 2+ mobilization via protein kinase C activation in human gingival fibroblasts. Cell Calcium. 1997;21:345-352.
33. Baron A, Frieden M, Chabaud F, Beny JL. Ca(2+)-dependent non-selective cation and potassium channels activated by bradykinin in pig coronary artery endothelial cells. J Physiol (Lond). 1996;493: 691-706.
34. Bowie D, Feltz P, Schlichter R. Subpopulations of neonatal rat sensory neurons express functional neurotransmitter receptors which elevate intracellular calcium. Neuroscience. 1994;58:141-149.
35. 2+ influx in Swiss 3t3 fibroblasts in response to receptor stimulation. Biochem J. 1998;329:107-114.
36. Parekh A, Penner R. Store depletion and calcium influx. Physiol Rev. 1997;77:901-930.
37. Walker K, Perkins M, Dray A. Kinins and kinin receptors in the nervous system. Neurochem Int. 1995;26:1-16.
38. Pozzan T, Rizzuto R, Volpe P. Meldolesi J. Molecular and cellular physiology of intracellular calcium stores.Physiol Rev. 1994;74: 595-636.
39. Lepple Wienhues A, Rauch R, Clark AF, Grassmann A, Berweck S, Wiederholt M. Electrophysiological properties of cultured human trabecular meshwork cells. Exp Eye Res. 1994;59:305-311.
40. Erickson KA, Schroeder A, Netland PA. Verapamil increases outflow facility in the human eye. Exp Eye Res. 1995;61:565-567.
41. Lepple Wienhues A, Stahl F, Willner U, Schafer R, Wiederholt M. Endothelin-evoked contractions in bovine ciliary muscle and trabecular meshwork: interaction with calcium, nifedipine and nickel. Curr Eye Res. 1991;10:983-989.
42. Stumpff F, Strauss O, Boxberger M, Wiederholt M. Characterization of maxi-K-channels in bovine trabecular meshwork and their activation by cyclic guanosine monophosphate. Invest Ophthalmol Vis Sci. 1997;38:1883-1892.
43. Lepple Wienhues A, Stahl F, Wiederholt M. Differential smooth muscle-like contractile properties of trabecular meshwork and ciliary muscle. Exp Eye Res. 1991;53:33-38.
44. Wiederholt M, Sturm A, Lepple Wienhues A. Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide. Invest Ophthalmol Vis Sci. 1994;35:2515-2520.
45. de Kater AW, Spurr Michaud SJ, Gipson IK. Localization of smooth muscle myosin-containing cells in the aqueous outflow pathway. Invest Ophthalmol Vis Sci. 1990;31:347-353.
46. Flugel C, Tamm E, Lutjen Drecoll E. Different cell populations in bovine trabecular meshwork: an ultrastructural and immunocytochemical study. Exp Eye Res. 1991;52:681-690.
47. Kashiwagi K, Lindsey JD, Kashiwagi F, Tsukahara S, Weinreb RN. Calponin distribution in human ciliary muscle and other anterior segment tissues. Invest Ophthalmol Vis Sci. 1997;38:349-356.
48. Tamm E, Russell P, Piatigorsky J. Initiation and characterization of an immortal, clonal and differentiated murine trabecular meshwork cell line [ARVO Abstract]. Invest Ophthalmol Vis Sci. 1997;38(4):S452.
49. Tamm ER, Siegner A, Baur A, Lutjen Drecoll E. Transforming growth factor-beta 1 induces alpha-smooth muscle-actin expression in cultured human and monkey trabecular meshwork. Exp Eye Res. 1996;62:389-397.
50. Grierson I, Millar L, De Yong J, et al. Investigations of cytoskeletal elements in cultured bovine meshwork cells. Invest Ophthalmol Vis Sci. 1986;27:1318-1330.
51. Zadunaisky J, Spring K. TBM cells area changes induced by drugs. Is it contraction or cell volume regulation [ARVO Abstract]? Invest Ophthalmol Vis Sci. 1995;36(4):S194. Abstract nr 906.
52. Zadunaisky J, Croft D, Spring K. Human trabecular meshwork cells receptors [ARVO Abstract] J. Invest Ophthalmol Vis Sci. 1996; 37(3):S205. Abstract nr 948.
53. Bataller R, Nicolás JM, Ginès P. et al. Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells. Gastroenterology. 1997;113:615-624.
54. Allen BG, Walsh MP. The biochemical basis of the regulation of smooth-muscle contraction. Trends Biochem Sci. 1994;19:362-368.
55. Horowitz A, Menice CB, Laporte R, Morgan KG. Mechanisms of smooth muscle contraction. Physiol Rev. 1996;76:967-1003.
56. Means AR, Dedman JR, Calmodulin: an intracellular calcium receptor. Nature. 1980;285:73-77.
57. Clapham DE. Calcium signaling. Cell. 1995;80:259-268.
58. Walsh MP. Calmodulin and the regulation of smooth muscle contraction. Mol Cell Biochem. 1994;135:21-41.
59. Yaney GC, Sharp GW. Calmodulin and insulin secretion: use of naphthalenesulfonamide compounds. Am J Physiol. 1990;259: E856-E864.
60. Kaufman PL, Barany EH, Erickson KA. Effect of serotonin, histamine and bradykinin on outflow facility following ciliary muscle retrodisplacement in the cynomolgus monkey. Exp Eye Res. 1982; 35:191-199.
61. Wiederholt M, Stumpff F. The trabecular meshwork and aqueous humor reabsorption In: Civan M, ed. The Eye's Aqueous Humor. From Secretion to Glaucoma. San Diego: Academic Press; 1998: 163-202.
62. Ye W, Gong H, Sit A, Johnson M, Freddo TF. Interendothelial junctions in normal human Schlemm's canal respond to changes in pressure. Invest Ophthalmol Vis Sci. 1997;38:2460-2468.